Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The PEERLESS II Study

NCT: NCT06055920 · ACTIVE_NOT_RECRUITING

NCT IDNCT06055920
StatusACTIVE_NOT_RECRUITING
Start Date2023-11-17
SponsorInari Medical (INDUSTRY)
First posted
Last updated

Brief Summary

This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑